Dr. Mark E. Elzik, MD

Dr. Elzik practices at Mission Surgery Center - Mission Viejo in Mission Viejo, California.

Dr. Elzik's NPI, 1093904302, was assigned on October 23, 2007. Dr. Elzik graduated from University of North Carolina School of Medicine in 2007. Dr. Elzik holds California license A107354.

Dr. Elzik's primary practice is Mission Surgery Center - Mission Viejo, at 26730 Crown Valley Pkwy, 1st Floor, Mission Viejo, CA 92691. The practice phone is (714) 364-2201.

Dr. Elzik's primary practice is Mission Surgery Center - Mission Viejo in Mission Viejo, California. Dr. Elzik is also affiliated with Providence Mission Hospital. The medical group on file is Orthopaedic Specialty Institute. Dmand AI also links Dr. Elzik to 1 more hospital, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elzik practices, 4 sites in all. Vendor and product names are available with a free account.

Hand surgery is Dr. Elzik's primary specialty in the NPI Registry, under taxonomy code 207XS0106X. Dr. Elzik is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Elzik's licenses on file in 3 states: California, Pennsylvania and New Jersey.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation and joint arthropathy among the conditions Dr. Elzik treats.

CMS data shows 7,575 Medicare services from Dr. Elzik across 26 procedure codes in 2024, for 527 Medicare patients. Medicare paid $334,454 for them.

CMS counts 527 Medicare patients who saw Dr. Elzik in 2024. The largest group is 65 to 74, with 278 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Elzik's median patient age at 64, with 53% women.

In 2024, Dr. Elzik wrote 379 Medicare Part D claims for 166 patients. 99% of them were for generic drugs. CMS names the drug for 340 of them, across 5 drugs with 11 or more claims each, at $1,923 in total drug cost. In 2023, CMS named 249 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Elzik for performance year 2024, reported as part of a group. Dr. Elzik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elzik as offering telehealth.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper limb (arm) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Elzik. The most frequent topics are Blood Transfusion and Hematocrit. Dr. Elzik's most frequent co-authors are Douglas R. Dirschl, Mohammad Diab, MD and Dimitriy G. Kondrashov, MD.

CMS Open Payments shows 509 general payments to Dr. Elzik from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Endo Pharmaceuticals Inc. paid the most, $179,122.

Dmand AI lists 1 award for Dr. Elzik, most recently CMS Stage 1 EHR in 2013.

Dr. Elzik graduated from University of North Carolina School of Medicine in 2007.

Dr. Elzik is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.